Scarica l'app Stockscreener
79.36
4.34%
-3.60
Dopo l'orario di chiusura:
78.94
-0.42
-0.53%
Precedente Chiudi:
$82.96
Aprire:
$79.94
Volume 24 ore:
362.59K
Relative Volume:
1.33
Capitalizzazione di mercato:
$3.65B
Reddito:
$305.11M
Utile/perdita netta:
$-196.00K
Rapporto P/E:
-12,209.23
EPS:
-0.0065
Flusso di cassa netto:
-
1 W Prestazione:
+11.09%
1M Prestazione:
+0.90%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$76.28
$84.90
Intervallo di 1 settimana:
$67.00
$85.00
Portata 52W:
$61.96
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Nome
Billiontoone Inc
Settore
Industria
Telefono
650-460-2551
Indirizzo
1035 O'BRIEN DRIVE, MENLO PARK
Compare BLLN vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
79.36 | 3.65B | 305.11M | -196.00K | 0 | -0.0065 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Iniziato | Guggenheim | Buy |
| 2025-12-01 | Iniziato | BTIG Research | Buy |
| 2025-12-01 | Iniziato | JP Morgan | Overweight |
| 2025-12-01 | Iniziato | Jefferies | Hold |
| 2025-12-01 | Iniziato | Piper Sandler | Overweight |
| 2025-12-01 | Iniziato | Stifel | Buy |
| 2025-12-01 | Iniziato | Wells Fargo | Equal Weight |
| 2025-12-01 | Iniziato | William Blair | Outperform |
Mostra tutto
Billiontoone Inc Borsa (BLLN) Ultime notizie
BillionToOne, Inc. (BLLN) Options Chain - Yahoo! Finance Canada
BillionToOne appoints Allen Chen as oncology VP By Investing.com - Investing.com Canada
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge - Investing.com
BillionToOne appoints Allen Chen as oncology VP - Investing.com
Billiontoone appoints Dr. Allen Chen as vice president of medical affairs and clinical development, oncology - MarketScreener
Billiontoone Appoints Dr. Allen Chen As Vice President Of Medical Affairs And Clinical Development, Oncology - TradingView
BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology - Bitget
BillionToOne puts 20-year cancer leader over Northstar medical strategy - Stock Titan
BLLN Technical Analysis | Trend, Signals & Chart Patterns | BILLIONTOONE INC CL A (NASDAQ:BLLN) - ChartMill
Top Billiontoone (BLLN) Competitors 2026 - MarketBeat
Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $100 - Moomoo
InvestingPro spotted BillionToOne’s 46% drop four months in advance By Investing.com - Investing.com
Why BillionToOne, Inc. Class A Shares Are Sinking - TipRanks
BillionToOne And 2 More Growth Companies With Strong Insider Ownership - Yahoo Finance
BillionToOne Inc (BLLN) Shares Up 3.33% on Mar 25 - GuruFocus
BillionToOne, Inc.(NasdaqGS: BLLN) added to S&P Global BMI Index - MarketScreener
Piper Sandler reiterates BillionToOne stock rating on NIPT tech By Investing.com - Investing.com Nigeria
Piper Sandler reiterates BillionToOne stock rating on NIPT tech - Investing.com
Billiontoone (BLLN) Stock Trends and Sentiment 2026 $BLLN - MarketBeat
BillionToOne Inc (BLLN) Stock Price Up 3.48% on Mar 16 - GuruFocus
Billiontoone (BLLN) Stock Forecast and Price Target 2026 $BLLN - MarketBeat
BillionToOne (NASDAQ: BLLN) Shares Climb 8% Amid Strong Momentum in Precision Diagnostics Sector - International Business Times Australia
BTIG lowers BillionToOne stock price target on valuation multiples - Investing.com Nigeria
BillionToOne, Inc.: Fundamental Analysis and Financial Ratings | BLLN | US0901681058 - marketscreener.com
BillionToOne Inc (BLLN) Shares Up 6.14% on Mar 13 - GuruFocus
BillionToOne’s Single-Molecule Next-Generation Sequencing Platform Redefines Molecular Diagnostics for Prenatal and Oncology Care 404148 - Minichart
BillionToOne 10-K: Revenue $305.1M, EPS $0.14 - TradingView
Billiontoone (NASDAQ:BLLN) Hits New 1-Year LowHere's What Happened - MarketBeat
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), BillionToOne, Inc. Class A (BLLN) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Billiontoone, Inc. (NASDAQ:BLLN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
BillionToOne Medicare Win Puts North Star Economics In Focus - Yahoo Finance
BillionToOne Market Share Gains Raise Questions On Undervalued BLLN Stock - simplywall.st
BLLN (BillionToOne) PB Ratio : (As of Mar. 07, 2026) - GuruFocus
Wall Street Zen Upgrades Billiontoone (NASDAQ:BLLN) to "Buy" - MarketBeat
BillionToOne (BLLN) Turns Profitable As Q4 EPS And Margins Challenge Bearish Narratives - simplywall.st
BillionToOne: Delivering And Lagging At The Same Time (NASDAQ:BLLN) - Seeking Alpha
Analysts Are Bullish on These Healthcare Stocks: BillionToOne, Inc. Class A (BLLN), Concentra Group Holdings Parent, Inc. (CON) - The Globe and Mail
What Makes BillionToOne (BLLN) an Attractive Bet? - Yahoo Finance
BTIG Maintains Buy on BillionToOne, Inc. (BLLN) March 2026 - Meyka
Billiontoone (NASDAQ:BLLN) Sees Large Volume Increase on Better-Than-Expected Earnings - MarketBeat
BillionToOne Q4 2025 Results: Profit & Revenue Surpass ForecastsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Assessing BillionToOne (BLLN) Valuation After Recent Share Price Volatility - simplywall.st
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge By Investing.com - Investing.com Nigeria
Wells Fargo & Company Has Lowered Expectations for Billiontoone (NASDAQ:BLLN) Stock Price - MarketBeat
BTIG lowers BillionToOne stock price target on valuation multiples By Investing.com - Investing.com India
Billiontoone's (BLLN) "Buy" Rating Reiterated at Guggenheim - MarketBeat
Billiontoone (NASDAQ:BLLN) Price Target Lowered to $140.00 at BTIG Research - MarketBeat
BLLN: BTIG Analyst Lowers Price Target Amid Maintained 'Buy' Rat - GuruFocus
BillionToOne Swings To Profit In Q4; Lifts FY26 Guidance - Nasdaq
Billiontoone Inc Azioni (BLLN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.17%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):